China Pharma Holdings, Inc. (CPHI)
-NYSE MKT 0.24 
0.03(11.79%) May 24, 4:00PM EDT
| Prev Close: | 0.21 |
|---|
| Open: | 0.21 |
|---|
| Bid: | 0.20 x 1700 |
|---|
| Ask: | 0.25 x 200 |
|---|
| 1y Target Est: | 3.00 |
|---|
| Beta: | 1.87 |
|---|
| Next Earnings Date: | 12-Aug-13 |
|---|
| Day's Range: | 0.21 - 0.24 |
|---|
| 52wk Range: | 0.18 - 0.55 |
|---|
| Volume: | 37,776 |
|---|
| Avg Vol (3m): | 61,522 |
|---|
| Market Cap: | 10.33M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.02 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- CHINA PHARMA HOLDINGS, INC. FinancialsEDGAR Online Financials(Tue, May 21)
- China Pharma Holdings' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 15)
- China Pharma Holdings, Inc. Earnings Call scheduled for 8:30 am ET todayCCBN(Wed, May 15)
- Q1 2013 China Pharma Holdings, Inc. Earnings Release - Time Not SuppliedCCBN(Wed, May 15)
- China Pharma Holdings, Inc. Reports First Quarter 2013 Financial ResultsPR Newswire(Wed, May 15)
- CHINA PHARMA HOLDINGS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, May 14)
- CPHI to Hold First Quarter of Fiscal Year 2013 Earnings Conference Call on Wednesday, May 15, 2013 at 8:30 a.m. ETPR Newswire(Mon, May 6)
- China Pharma Holdings' CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha(Fri, Mar 15)
- China Pharma Holdings, Inc. Earnings Call scheduled for 8:30 am ET todayCCBN(Fri, Mar 15)
- Q4 2012 China Pharma Holdings, Inc. Earnings Release - Before Market OpenCCBN(Fri, Mar 15)
- China Pharma Holdings, Inc. Reports Full Year 2012 Financial ResultsPR Newswire(Fri, Mar 15)
- CHINA PHARMA HOLDINGS, INC. Files SEC form 10-K, Annual ReportEDGAR Online(Thu, Mar 14)
- CPHI to Hold Fiscal Year 2012 Earnings Conference Call on Friday, March 15, 2013 at 8:30 a.m. ETPR Newswire(Tue, Mar 5)
- CHINA PHARMA HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification toEDGAR Online(Fri, Jan 4)
- CHINA PHARMA HOLDINGS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Wed, Dec 26)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 0.20 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-11)
: | N/A |
|---|
| Quarterly EPS Est
(Dec-11)
: | N/A |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical products primarily to hospitals and private retailers in the Peoples Republic of China.
View More